Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
Clinical trial NCT02241187 · COMPLETED
Trial details
- NCT number
- NCT02241187
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-12
- Primary completion
- 2016-09-13
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.